Skip to Content
Top

BY Scott Merville

Combination immunotherapy is producing response rates ranging from 26 to 38% among patients with metastatic bladder cancer in a clinical trial led by MD Anderson Cancer Center.

“Until the first, recent approval of immune checkpoint therapy, patients with bladder cancer have not had new treatment options for over 30 years. We’re quickly moving from immune checkpoint monotherapy to immune checkpoint combination therapies to improve...

bladder cancer combination immunotherapy treatment clinical trial

BY Scott Merville

The largest analysis of metastatic melanoma patients who received a targeted therapy combination shows the treatment provides long-term survival...

BY MD Anderson staff

A new trial underway at MD Anderson may lead to new therapies for triple negative breast cancer.

Fifteen to 20% of breast cancers...

BY Ron Gilmore

Patients who’ve been successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).

A study conducted by researchers at MD Anderson Cancer Center revealed pre-leukemic mutations, called clonal hematopoiesis, may predict...

therapy-related myeloid neoplasms leukemia

BY Scott Merville

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81% of indoor tanning facilities complied...

BY Julie Penne

The University of Texas Health Science Center at San Antonio and The University of Texas MD Anderson Cancer Center are announcing...

BY Clayton Boldt, Ph.D.

Three years ago, Stephen Cadmus faced a dilemma. He needed to see a doctor, but he had no health insurance.

To get the medical...

BY Ronda Wendler

Chemistry professor Bindu Chakravarty rarely missed a day teaching at Houston Community College. So when she called in sick one morning, it...

BY Scott Merville

The first clinical study of a new drug designed to kill cancer cells by depriving them of the nutrients they need to survive is underway at...

BY Ronda Wendler

Jan Barbo likely got hepatitis C from a blood transfusion. Almost 50 years ago, she suffered an ectopic pregnancy when a fertilized egg attached...

BY Bryan Tutt

The most common malignant brain tumors in children, medulloblastomas, are usually incurable if they recur. Even with surgery, chemotherapy...

BY Laura Sussman

Two drugs used together — ribociclib and letrozole, improve progression-free survival of post-menopausal women diagnosed with hormone receptor-positive...

BY Clayton Bold, Ph.D.

The American Lung Association and MD Anderson Cancer Center have announced a new partnership aimed at increasing coverage and access...

BY Clayton Boldt, Ph.D.

Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, a new MD Anderson...

BY Ron Gilmore

Researchers at MD Anderson have discovered a potentially new therapeutic approach for certain brain cancers in which the enzyme enolase (ENO1...

BY Ron Gilmore

A genome-wide association study has tied common genetic variants to pre-treatment pain, a finding with potential implications for precision...

BY Ron Gilmore

A study in mice combining two inhibitor drugs for treatment of chronic myeloid leukemia (CML) has revealed potential for stopping the disease...

BY Clayton Boldt, Ph.D.

Cervical cancer is the fourth most common cancer among women worldwide and was responsible for approximately 266,000 deaths in 2012, according...

BY Laura Sussman

Mastectomy plus reconstruction for patients with early-stage breast cancer is significantly riskier and costlier than other less-invasive...

BY Scott Merville

In a pilot study of 13 newly diagnosed, BRCA-positive breast cancer patients at MD Anderson, all had their tumors shrink significantly when...

BY Scott Merville

“Loss of interferon-gamma signaling caused by these mutations is the first clearly defined resistance pathway to ipilimumab found in tumor...

BY Clayton Boldt, Ph.D.

Hereditary cancers are caused by genetic mutations passed down from parents to children. The National Cancer Institute estimates...

BY Bryan Tutt

The human papillomavirus (HPV) is known to cause a variety of cancers, but screening guidelines and a reliable early-detection test exist...

BY Clayton Boldt, Ph.D.

According to a recent report from the Centers for Disease Control and Prevention (CDC), adolescent vaccination rates for the human...

BY Ronda Wendler

A program designed to reduce cervical- and breast-cancer deaths among women in developing countries is celebrating its fifth anniversary this...

BY Ronda Wendler

When Allison Easley awoke one morning with soreness under her right armpit, she thought she’d pulled a muscle. But the pain soon became worse...

BY Scott Merville

A study that indicates how advanced melanoma responds to an immunotherapy, published in Cancer Discovery, demonstrates a revolutionary...

BY Ron Gilmore

MD Anderson Cancer Center has been awarded $19.1 million in research grants in the most recent round of funding from the Cancer...

BY Ron Gilmore

Two cellular pathways have been shown to play a role in regulating the immune-system protein PDL1, a finding that could lead to increased...

BY Ron Gilmore

As with most cancers, triple-negative breast cancer (TNBC) cells have abnormal amounts of chromosomes or DNA copy number aberrations (CNAs...

BY Julie Penne

MD Anderson again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” rankings. Since the rankings...

BY Sarah Bronson

Chemotherapy, radiation, hormone therapy, various cancer drugs and even cancer itself can weaken patients’ bones, leading to cancer-related...

BY Ron Gilmore

Up to 15% of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been known...

BY Ron Gilmore

Reported online in the July 28 issue of Molecular Cell, a study conducted at MD Anderson has shown that a protein called ZMYND8 blocks expression...

BY Bryan Tutt

Patients diagnosed with blood-related cancers such as leukemia, lymphoma and multiple myeloma often undergo what is called a hematopoietic...

BY Clayton Boldt, Ph.D.

Tobacco use has significantly declined during the past five decades since the release of the U.S. Surgeon General’s Report on Smoking &amp...

BY Scott Merville

Researchers with MD Anderson’s Colorectal Cancer Moon Shot are sharpening the focus of a genetic tool designed to classify colorectal cancer...

BY Ron Gilmore

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic...

BY Lany Kimmons

Early-stage breast cancer patients receiving a shorter course of whole-breast radiation with higher radiation doses reported equivalent cosmetic...

BY Jill Delsigne

Proton therapy can deliver a higher radiation dose to lung tumors and a lower dose to healthy tissue compared to standard radiation therapy...

BY Scott Merville

Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice,...

BY Clayton Boldt, Ph.D.

This summer, many preschoolers across Texas are safely enjoying their vacation time outdoors thanks to Ray and the Sunbeatables™, a sun-safety...

BY Ron Gilmore

A mitogen-activated protein kinase (MAP) known as p38 appears to show promise for halting breast cancer metastasis, and may point to the potential...

BY Scott Merville

Separate immunotherapies work well together, pumping up the impact of immune system attack on tumors, an unprecedented clinical trial shows...

BY Laura Sussman

Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of key studies were presented by researchers...

BY Laura Sussman

Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new...

BY Ron Gilmore

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular...

BY Ronda Wendler

When Gene Duncan visited his family doctor for a respiratory infection, little did he realize he’d be diagnosed with bronchitis — and something...

BY Ronda Wendler

An MD Anderson study is seeking new drugs to combat triple-negative breast cancer, an aggressive form of the disease that doesn’t rely on...

BY Laura Sussman

The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless...

BY Laura Sussman

Lung cancer patients whose cancer has spread to three or fewer sites may benefit from aggressive surgery or radiation after completing standard...

BY Scott Merville

Patients in a first-of-its-kind clinical trial will receive a vastly expanded dose of their own T cells — white blood cells that are the specialized...

BY Ron Gilmore

The 90 percent of cancer patients who experience pain due to nerve damage caused by tumors, surgery, chemotherapy or radiation may someday...

BY Ron Gilmore

Researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab on...

BY Ron Gilmore

Receptors for leptin, a protein hormone, may be associated with tumor recurrence in patients with renal cell carcinoma (RCC), providing further...

BY Sarah Watson

Eight of MD Anderson Cancer Center's top young researchers have been named Andrew Sabin Family Fellows and will receive $100,000 over two...

BY Ron Gilmore

Researchers at MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology...

BY Clayton Boldt, Ph.D.

The Affordable Care Act (ACA) was signed into law in 2010 to improve access to affordable health coverage for Americans, and a major focus...

BY Ron Gilmore

The drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a new MD...

BY Clayton Boldt, Ph.D.

MD Anderson Cancer Center fully supports new rules recently issued by the Food and Drug Administration (FDA) to extend federal regulatory...

BY Laura Sussman

Long associated with liver cancer and non-Hodgkin’s lymphoma, the hepatitis C virus (HCV) for the first time has been associated with certain...

BY Ron Gilmore

A long non-coding RNA (lncRNA) called NBR2, once considered to be a “junk” gene, may very well play a significant role in tumor development...

BY Laura Sussman

A new breast cancer staging system developed by researchers at MD Anderson Cancer Center finds that incorporating tumor biology is a critical...

BY Clayton Boldt, Ph.D.

Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated...

BY Laura Sussman

Using the latest advances in endoscopic resection techniques, more than 75 percent of patients with complex colon polyps could avoid surgery...

BY Scott Merville

A new clinic to identify and monitor those at high risk for developing pancreatic cancer continues to expand after opening last year....

BY Jill Delsigne

Cancer survivors are more likely to die from heart disease than cancer; therefore, patients must be closely monitored for heart problems during...

BY Scott Merville

Cancer immunotherapy leaders at MD Anderson Cancer Center will work with experts at five other cancer centers in a new alliance funded by...

BY Scott Merville

Two cancer experts at The University of Texas MD Anderson Cancer Center have been named to a blue ribbon panel to advise the National Cancer...

BY Laura Sussman

MD Anderson researchers are proposing a new model to allow doctors to predict outcomes more accurately for patients with oropharyngeal (middle...

BY Ron Gilmore

New findings about where and how aggressive forms of prostate cancer potentially begin may lead to new therapies for hard-to-treat and lethal...

BY Ron Gilmore

ONC201, an anti-cancer drug that triggers cell death in various tumor types, may be effective in treating some blood cancers, including mantle...

BY Clayton Boldt, Ph.D.

Looking at data from a standard technology in a novel way, MD Anderson researchers have discovered that certain genetic aberrations are two...

BY Scott Merville

The nation’s premier cancer research group, oncology society and 20 other organizations recently released a statement calling for state and...

BY Clayton Boldt, Ph.D.

In response to low national vaccination rates for the human papillomavirus (HPV), The University of Texas MD Anderson Cancer Center has joined...

BY Clayton Boldt, Ph.D.

Loretta Preston kicked her cigarette addiction two years ago.

“Quitting wasn’t easy,” she says. “I’d smoked for 40 years.” Then, the...

BY Ron Gilmore

An international study has revealed new information about diffuse glioma, the most common type of tumor found in some 80% of adult brain cancer...

BY Laura Sussman

Is the best way to treat an early precursor to breast cancer no treatment at all? That’s what MD Anderson researchers and allied institutions...

BY Laura Sussman

A new procedure developed by MD Anderson surgeons is helping doctors determine which lymph nodes in breast cancer patients are cancerous and...

BY Scott Merville

After extensive internal and external peer review, MD Anderson expanded its Moon Shots Program by adding six new moon shots to its focused...

BY MD Anderson staff

Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed to...

BY Ron GIlmore

In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.

A multi-institutional...

BY Laura Sussman

The 140,000 U.S. women diagnosed each year with early-stage breast cancer, when the tumor is still small and hasn’t spread, have a variety...

BY Karen Lu, M.D. and Mark Ebell, M.D.

The majority of women diagnosed with ovarian cancer face a difficult journey of repeated treatments that include aggressive surgeries and...

BY Scott Merville

Researchers at MD Anderson have found that pancreatic cancer tumors essentially spill their molecular secrets when they shed their complete...

BY Clayton Boldt, Ph.D.

Breast cancer patients who delay chemotherapy more than 90 days after surgery are one-third more likely to die within five years, compared...

BY Clayton Boldt, Ph.D.

Depression significantly impacts five-year survival and recurrence in head and neck cancer patients, according to a new MD Anderson study....

BY Ron Gilmore

Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer...

BY Ron GIlmore

High amounts of dietary sugar increased the risk that mice would develop breast cancer, and that it would spread to their lungs, MD Anderson...